# FDA recall D-310-2013

> **Reckitt Benckiser Inc** · Class III · drug recall initiated 2013-03-18.

## Product

Cherry Cepacol Sore Throat Lozenges, Benzocaine 15 mg | Menthol 3.6 mg, a)16-count, NDC 63824-711-16 b) Institutional Size, 576-count, NDC 63824-711-98, OTC,  Dist. by: Reckitt Benckiser, Parsippany, NJ  07054

## Reason for recall

Subpotent Drug: Product did not conform  to the 18-month stability test specification for active Free Benzocaine.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-310-2013
- **Recalling firm:** Reckitt Benckiser Inc
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-03-18
- **Report date:** 2013-05-08
- **Termination date:** 2014-08-14

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Parsippany, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-310-2013

## Citation

> AI Analytics. FDA recall D-310-2013. Retrieved 2026-05-27 from https://api.ai-analytics.org/recall/D-310-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*